救援吸入器市场：按产品类型、适应症、患者类型、剂型、最终用户和地区划分

救援吸入器市场规模预计在 2025 年达到 199.5 亿美元，预计到 2032 年将达到 360 亿美元，2025 年至 2032 年的复合年增长率为 8.8%。

急救吸入器，也称为缓解吸入器，是气喘和慢性阻塞性肺病(COPD) 等呼吸系统疾病患者常用的药物设备。它们含有速效支气管扩张剂，可在气喘发作或呼吸困难时扩张气道。这种药物可以快速缓解喘息、呼吸急促和胸闷等症状。虽然急救吸入器可以快速缓解症状，但它们并不能治疗症状的根本原因。它们是控制急性呼吸道症状和改善患者生活品质的重要工具。

市场动态：

预计呼吸系统疾病盛行率上升、老年人口成长以及医疗保健支出上涨将在预测期内推动全球急救吸入器市场的成长。此外，技术进步也有望在预测期内推动全球急救吸入器市场的成长。新兴市场的高成长潜力、居家照护环境需求的不断增长、气喘生技药品的开发以及对呼吸照护远端医疗日益增长的关注，预计将在预测期内为全球急救吸入器市场带来成长机会。

然而，严格的监管要求、吸入器的副作用以及吸入器的高成本预计将在预测期内阻碍救援吸入器市场的成长。

本研究的主要特点

• 本报告对救援吸入器市场进行了详细分析，并提供了预测期 2025-2032 的市场规模和年复合成长率（CAGR%），假设 2024 年为基准年。
• 它揭示了不同领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，介绍了救援吸入器市场的主要企业概况。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 救援吸入器市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
• 相关人员将透过用于分析救援吸入器市场的各种战略矩阵更轻鬆地做出决策。

目录

第一章 调查目的与前提条件

• 研究目标
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第三章市场动态、法规与趋势分析

• 市场动态
  • 驱动程式
• 呼吸系统疾病盛行率上升
• 人口老化加剧
• 提高产品核可
  • 限制因素
• 严格的监管要求
• 产品召回
• 吸入器高成本
  • 机会
• 远端医疗在呼吸照护领域获得青睐
• 气喘生物製药的开发
• 新兴市场具有高成长潜力
• 影响分析
• 主要亮点
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景

4. 救援吸入器市场-冠状病毒（COVID-19）大流行的影响

• COVID-19流行病学
• 供需侧分析
• 经济影响

5. 2020 年至 2032 年救援吸入器市场（依产品类型）

• 定量喷雾吸入器
• 干粉吸入器
• 喷雾器
• 缓雾吸入器
• 其他的

6. 救援吸入器市场（依适应症划分），2020 年至 2032 年

• 气喘
• COPD
• 过敏性鼻炎
• 肺动脉高血压
• 其他的

7. 救援吸入器市场（依病患类型），2020 年至 2032 年

• 成人
• 孩子们

8. 救援吸入器市场（依剂型划分），2020-2032 年

• 胶囊
• 液体
• 暂停
• 其他的

9. 2020 年至 2032 年救援吸入器市场（依最终使用者划分）

• 居家医疗
• 医院和诊所

第 10 章。 2020 年至 2032 年按地区分類的救援吸入器市场

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 北非
  • 南非
  • 中部非洲

第十一章竞争格局

• GSK plc.
• Teva Pharmaceutical Industries Ltd.
• Cipla Inc.
• PARI Pharma GmbH
• Lupin
• AstraZeneca
• Boehringer Ingelheim International GmbH.
• Novartis
• Pfizer
• Sunovion Pharmaceuticals
• 3M
• OMRON Healthcare Co., Ltd.
• Koninklijke Philips NV
• Invacare
• Schiller
• Teleflex Incorporated

第十二章 章节

• 调查方法
• 关于出版商

Rescue Inhaler Market is estimated to be valued at USD 19.95 Bn in 2025 and is expected to reach USD 36 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

A rescue inhaler, also known as a reliever inhaler, is a medication device commonly used by individuals with respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD). It contains a fast-acting bronchodilator medication that helps open up airways during an asthma attack or breathing difficulties. This medication quickly eases symptoms like wheezing, shortness of breath, and chest tightness. Rescue inhalers offer rapid relief, but they do not treat the underlying cause of the condition. They are an essential tool for managing acute respiratory symptoms and improving the patient's quality of life.

Market Dynamics:

Rising prevalence of respiratory diseases, increasing geriatric population, and rising healthcare expenditure are anticipated to drive growth of the global rescue inhaler market over the forecast period. Moreover, technological advancements is also expected to boost the growth of the global rescue inhaler market over the forecast period. High growth potential in emerging markets, growing demand for home care settings, development of biologics for asthma, rising focus on telehealth for respiratory care are expected to create growth opportunities for the global rescue inhaler market during the forecast period.

However, stringent regulatory requirements, side effects of inhalers, and high cost of inhalers are expected to hamper growth of the rescue inhaler market over the forecast period.

Key features of the study:

• This report provides an in-depth analysis of the rescue inhaler market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the rescue inhaler market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include GSK plc., Teva Pharmaceutical Industries Ltd., Cipla Inc., PARI Pharma GmbH, Lupin, AstraZeneca, Boehringer Ingelheim International GmbH., Novartis, Pfizer, Sunovion Pharmaceuticals, 3M, OMRON Healthcare Co., Ltd., Koninklijke Philips N.V., Schiller, and Teleflex Incorporated
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The rescue inhaler market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the rescue inhaler market

Rescue Inhaler Market Detailed Segmentation:

• By Product Type:
  • Metered Dose Inhalers
  • Dry Powder Inhalers
  • Nebulizers
  • Soft Mist Inhalers
  • Others
• By Indication:
  • Asthma
  • COPD
  • Allergic Rhinitis
  • Pulmonary Arterial Hypertension
  • Others
• By Patient Type:
  • Adult
  • Pediatric
• By Dosage Form:
  • Capsules
  • Solution
  • Suspension
  • Others
• By End User:
  • Home Care Settings
  • Hospitals & Clinics
• By Region:
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
• Company Profile:
  • GSK plc.
  • Teva Pharmaceutical Industries Ltd.
  • Cipla Inc.
  • PARI Pharma GmbH
  • Lupin
  • AstraZeneca
  • Boehringer Ingelheim International GmbH.
  • Novartis
  • Pfizer
  • Sunovion Pharmaceuticals
  • 3M
  • Omron Healthcare
  • Koninklijke Philips N.V.
  • Invacare
  • Schiller
  • Teleflex Incorporated

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Product Type
  • Market Snippet, By Indication
  • Market Snippet, By Patient Type
  • Market Snippet, By Dosage Form
  • Market Snippet, By End User
  • Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Rising prevalence of respiratory diseases
• Increasing geriatric population
• Increasing Product Approval
  • Restraints
• Stringent regulatory requirements
• Product Recall
• High cost of inhalers
  • Opportunities
• Rising focus on telehealth for respiratory care
• Development of biologics for asthma
• High growth potential in emerging markets
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Rescue Inhaler Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Rescue Inhaler Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Metered Dose Inhalers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Dry Powder Inhalers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Nebulizers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Soft Mist Inhalers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Rescue Inhalers Market, By Indication, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Asthma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• COPD
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Allergic Rhinitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Pulmonary Arterial Hypertension
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Rescue Inhalers Market, By Patient Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Rescue Inhalers Market, By Dosage Form, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Capsules
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Suspension
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

9. Rescue Inhalers Market, By End User, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Hospitals & Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

10. Rescue Inhalers Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • UK
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032, (US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
    • North Africa
    • South Africa
    • Central Africa

11. Competitive Landscape

• GSK plc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Cipla Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• PARI Pharma GmbH
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Lupin
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Boehringer Ingelheim International GmbH.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Novartis
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sunovion Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• 3M
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• OMRON Healthcare Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Koninklijke Philips N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Invacare
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Schiller
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Teleflex Incorporated
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

12. Section

• Research Methodology
• About us